Jonathan Pearson-Stuttard
Jonathan is a public health doctor and chair of the Royal Society for Public Health.
Comment'Trusted' NHS must bring R&D benefits to the disadvantaged
Realignment of R&D investment could generate a better return on R&D investment to UK plc by improving access to innovative medicines, reducing variations in health outcomes, reengaging people with the labour market, and improving healthy life expectancy, write Jonathan Pearson-Stuttard and James O’Shaughnessy.